Welcome to our dedicated page for DUKE Robotics SEC filings (Ticker: DUKR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Duke Robotics Corp. filings document registration-statement activity, material-event reports, governance changes, and capital-structure disclosures for the company’s robotics and drone-technology business. Its S-1 and S-1/A filings cover securities offering registration matters, while Form 8-K reports disclose corporate events and Regulation FD materials.
The company’s filings also address amendments to its articles of incorporation, including authorized common stock and blank-check preferred stock provisions, equity incentive plan share reserves, private placement terms, material agreements, shareholder voting matters, and other financing or governance disclosures.
Duke Robotics Corp. has updated its 2021 Equity Incentive Plan to clarify that a total of 480,000 shares of common stock are issuable under the plan. The share pool was previously increased by the board of directors from 192,000 to 360,000 shares and then to 480,000 shares, with the latest change approved on March 10, 2026.
DUKE Robotics Corp. director Antebi Eran received an option grant for 4,000 shares of common stock at an exercise price of $7.88 per share. The option was fully unheld before this award, so his post-transaction derivative holdings in this grant are 4,000 options. The option vests in three equal annual installments beginning on March 10, 2027, and expires on March 10, 2032. This is a compensation-related award, not an open-market trade.
Zakai Shlomo reported acquisition or exercise transactions in this Form 4 filing.
DUKE Robotics Corp. chief financial officer Zakai Shlomo received a grant of options to purchase 10,000 shares of common stock, exercisable at $7.88 per share. The option expires on March 10, 2032 and vests in three equal annual installments beginning on March 10, 2027.
DUKE Robotics Corp. director Golan Keren Gousman received an option grant for 4,000 shares of common stock at an exercise price of $7.88 per share, expiring on March 10, 2032. The option vests in three equal annual installments beginning on March 10, 2027.
DUKE Robotics Corp. reported that Chief Technology Officer Maor Vadim received a grant of options to purchase 4,000 shares of common stock at an exercise price of $7.88 per share. These options are a form of equity compensation rather than an open‑market trade.
The options expire on March 10, 2032 and vest in three equal annual installments beginning on March 10, 2027. After this award, Vadim holds options for 4,000 underlying shares directly, with no sales or exercises reported in this filing.
DUKE Robotics Corp. chief executive officer Balucka Yossef received a grant of options to purchase 16,000 shares of common stock at an exercise price of $7.88 per share. The options vest in three equal annual installments beginning on March 10, 2027 and expire on March 10, 2032. Following the grant, he holds 16,000 options directly.
DUKE Robotics Corp. director Nachtomy Erez received an option grant covering 16,000 shares of common stock at an exercise price of $7.88 per share. The option vests in three equal annual installments beginning on March 10, 2027, and expires on March 10, 2032. Following this grant, Erez holds options on 16,000 shares directly.
DUKE Robotics Corp. files its annual report describing a robotics business focused on stabilized weapon systems and civilian drone-based infrastructure maintenance, including its IC Drone insulator-cleaning platform and new AEROTRACE™ monitoring solution. The company relies on collaborations such as its Elbit Systems “Bird of Prey” defense partnership and commercial agreements with Israel Electric Corporation.
DUKE highlights significant capital structure activity, including private placements, warrant amendments, an authorized share increase to 350,000,000 common shares, a 25‑for‑1 reverse stock split and expansions of its 2021 Equity Incentive Plan. The report discloses that current cash is not sufficient for 12 months of operations, raising substantial doubt about its ability to continue as a going concern and emphasizing the need for additional financing.
The filing also outlines heavy dependence on government and quasi‑government customers, extensive regulatory exposure in Israel, the U.S. and Europe, and geopolitical risks tied to operations in Israel. As of March 11, 2026, DUKE had 2,252,151 common shares outstanding and a non‑affiliate equity market value of $4,120,827 as of its most recent second fiscal quarter.
Duke Robotics Corp. is implementing a 25-for-1 reverse stock split of its common stock, effective at 12:01 a.m. Eastern on March 6, 2026. Every twenty-five existing shares will be combined into one share, and fractional shares will be rounded up to the nearest whole share.
As of March 5, 2026 there were 56,302,147 common shares outstanding, which will become approximately 2,252,086 shares after the split. The company’s authorized common stock will remain at 350,000,000 shares, and par value and preferred stock authorization are unchanged. Proportionate adjustments will apply to outstanding options, warrants and equity awards.
The common stock will trade on a split-adjusted basis on the OTCQB beginning March 6, 2026, temporarily under the symbol DUKRD for 20 trading days and with new CUSIP 903448207. The company states that the primary purpose of the reverse split is to increase the per-share trading price and support a potential uplisting to a national securities exchange, subject to applicable listing requirements.
DUKE Robotics Corp. disclosed that it entered into Securities Purchase Agreements with seven non-U.S. investors for a private placement. The company agreed to sell 2,083,333 shares of common stock at $0.36 per share and issue Warrants to purchase an additional 2,083,333 shares at an exercise price of $0.65 per share.
The Warrants are exercisable immediately and expire on November 30, 2026, with a potential extension to May 30, 2028 if a qualifying public offering of at least $2,500,000 has not occurred by that date. The transaction is expected to generate aggregate gross proceeds of approximately $750,000, which will be used for general corporate purposes and working capital, including operational and commercialization initiatives.
The securities are being issued in a private, unregistered offering relying on exemptions under Section 4(a)(2), Rule 506(b) of Regulation D, and Regulation S, and may not be sold in the United States without registration or an applicable exemption.